SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-000879
Filing Date
2022-01-05
Accepted
2022-01-05 16:05:54
Documents
1
Period of Report
2022-01-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4011
  Complete submission text file 0000899243-22-000879.txt   5431
Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AYALA PHARMACEUTICALS, INC. OPPENHEIMER 4 REHOVOT L3 7670104
Business Address
Gordon Gary B. (Reporting) CIK: 0001811354 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39279 | Film No.: 22511131